Literature DB >> 11867103

Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.

Richard Day1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867103     DOI: 10.1016/S0140-6736(02)07718-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  33 in total

Review 1.  Adverse drug reactions: back to the future.

Authors:  Munir Pirmohamed; B Kevin Park
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

2.  Infliximab and serious hematologic events.

Authors:  Cynthia Phelan; Eric Wooltorton
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

3.  TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation.

Authors:  Hélène Le Buanec; Laure Delavallée; Natacha Bessis; Sébastien Paturance; Bernard Bizzini; Robert Gallo; Daniel Zagury; Marie-Christophe Boissier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

4.  TNF-α Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration.

Authors:  Masayuki Yamashita; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2019-06-20       Impact factor: 24.633

5.  Interaction of HLA-DRB1*1501 and TNF-Alpha in a Population-based Case-control Study of Multiple Sclerosis.

Authors:  Dhelia M Williamson; Ruth Ann Marrie; Allison Ashley-Koch; Glen A Satten
Journal:  Immunol Infect Dis       Date:  2013-09

6.  Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.

Authors:  A Picchianti Diamanti; M M Rosado; M Scarsella; V Germano; E Giorda; S Cascioli; B Laganà; R D'Amelio; R Carsetti
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 7.  TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.

Authors:  Lauren M Workman; Hasem Habelhah
Journal:  Cell Signal       Date:  2013-04-21       Impact factor: 4.315

8.  Biological therapy of psoriasis.

Authors:  Raja K Sivamani; Genevieve Correa; Yoko Ono; Michael P Bowen; Siba P Raychaudhuri; Emanual Maverakis
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

9.  Ethanol extract of Angelica gigas inhibits croton oil-induced inflammation by suppressing the cyclooxygenase - prostaglandin pathway.

Authors:  Sunhee Shin; Seong Soo Joo; Dongsun Park; Jeong Hee Jeon; Tae Kyun Kim; Jeong Seon Kim; Sung Kyeong Park; Bang Yeon Hwang; Yun-Bae Kim
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.672

10.  Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases.

Authors:  Siba P Raychaudhuri; Smriti K Raychaudhuri
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.